Home › Funds › MACQUARIE GROUP LTD › CVS
MACQUARIE GROUP LTD position in CVS
CVS HEALTH CORP · Consumer Staples
MACQUARIE GROUP LTD reported holding 1,593,454 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$136.5M, representing 0.72% of its reported portfolio and ranking #27 among its reported holdings. MACQUARIE GROUP LTD has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How MACQUARIE GROUP LTD's CVS position evolved
MACQUARIE GROUP LTD first disclosed a stake in CVS in Q3 2023 at 6,330,317 shares (US$442.0M). The position peaked in Q4 2023 at 5,639,126 shares, worth US$445.3M. Across 13 filings, MACQUARIE GROUP LTD increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,593,454 shares valued at US$136.5M — an increase of 277,595 shares quarter over quarter.. Notable position changes include a 68% trim in Q1 2025 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.33M | $441.98M | New |
| Q4 2023 | 5.64M | $445.27M | Reduce |
| Q1 2024 | 5.36M | $427.54M | Reduce |
| Q2 2024 | 5.22M | $308.43M | Reduce |
| Q3 2024 | 4.70M | $295.57M | Reduce |
| Q4 2024 | 4.85M | $215.41M | Add |
| Q1 2025 | 1.56M | $105.85M | Reduce |
| Q2 2025 | 1.58M | $108.74M | Add |
| Q3 2025 | 1.51M | $113.68M | Reduce |
| Q4 2025 | 1.36M | $107.53M | Reduce |
| Q1 2026 | 1.32M | $94.98M | Reduce |
| Q2 2026 | 1.32M | $136.09M | Reduce |
| Q3 2026 | 1.59M | $136.54M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.04M sh · $6.35B · Q3 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.90M sh · $1.02B · Q3 2026
- Pzena Investment Management 10.30M sh · $882.34M · Q3 2026
More on MACQUARIE GROUP LTD
FAQ
How long has MACQUARIE GROUP LTD held CVS?
MACQUARIE GROUP LTD has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is MACQUARIE GROUP LTD's current position in CVS?
As of Q3 2026, MACQUARIE GROUP LTD holds 1.59M shares of CVS (CVS HEALTH CORP), valued at $136.54M, representing 0.72% of its reported portfolio and ranking #27.
Has MACQUARIE GROUP LTD been buying or selling CVS?
In the latest 13F filing (Q3 2026), MACQUARIE GROUP LTD increased its position in CVS. The position peaked in Q4 2023 at 5.64M shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.